SCHEMBL4425311

SCHEMBL4425311

Cc1cn(CCC(=O)N2CCN(c3ccc(Cl)cc3)CC2Cc2ccccc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 2/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HTR1A P08908 2/20 0.41
▸ NR1H2 P55055 2/20 0.38
▸ NR1H3 Q13133 2/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA4 P22748 2/20 0.36
▸ CA9 Q16790 2/20 0.36
▸ GFER P55789 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ SLC6A9 P48067 1/20 0.36
▸ DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4430303 0.89 HTR7 (0.42) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4416267 0.83 LMNA (0.38) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4417268 0.82 HTR7 (0.43) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4417933 0.80 ESR1 (0.47) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4425309 0.75 HTR1A (0.42) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4419760 0.73 HTR7 (0.60) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL4417234 0.72 LMNA (0.39) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL2116079 0.71 MEN1 (0.49) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL587767 0.69 NR1H2 (0.48) HTR7MEN1MAPTKMT2AHTR1A
SCHEMBL587766 0.69 NR1H2 (0.48) HTR7MEN1MAPTKMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-12-31 — — US claimed
US-8492384-B2 Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-07-23 — — US disclosed
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF CACNA1B, CACNA1C, ORAI1 HTR7 816/4885MEN1 2657/4885MAPT 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback